Is systemic autoimmune disease a risk factor for terbinafine-induced erythema multiforme?
Authors:
- 1 March 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 142 (3) , 578-579
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Exacerbation of systemic lupus erythematosus induced by terbinafineBritish Journal of Dermatology, 1998
- Terbinafine-induced subacute cutaneous lupus erythematosusBritish Journal of Dermatology, 1998
- Terbinafine-induced lupus erythematosusBritish Journal of Dermatology, 1998
- Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literatureBritish Journal of Dermatology, 1998
- Safety of Oral TerbinafineArchives of Dermatology, 1997
- Oral terbinafine and erythema multiformeClinical and Experimental Dermatology, 1995
- Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine.Acta Dermato-Venereologica, 1994
- Stevens-Johnson syndrome after terbinafine therapyJournal of the American Academy of Dermatology, 1994